Market Samachar

FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks - STAT

Read full article on STAT ↗

Market Samachar is a news aggregator. This article was originally published by STAT. Tap the button above to read the full story on their site.

• INDIAN SIDBI withdraws ₹6,000 crore three-year bond issue as yields harden Share Market Today
• INDIAN Steel Authority of India and Bharat Coking Coal signs MoU Share Market Today
• INDIAN One 97 Communications hikes stake in its subsidiary - Little Internet Share Market Today
• INDIAN Lumax Auto Technologies announces change in senior management Share Market Today
• INDIAN PC Jeweller achieves debt-free status Share Market Today
• INDIAN Edelweiss concludes sale of 45% stake in Nido Home Finance Share Market Today
• INDIAN PB Fintech's 2-day fall costs mutual fund investors nearly ₹11,000 crore Share Market Today
• INDIAN PVR Inox opens 5-screen multiplex at MyMoon, Kochi Share Market Today

More from Market Samachar

• Is 'out of control' US tipping culture spreading overseas? BBC News
• Traders are skeptical of Iran timeline for Strait of Hormuz reopening Finance
• Stocks making the biggest moves after hours: Snowflake, Marvell Technology, Agilent Technologies & more Finance
• Boeing CEO says company met requirements to increase 737 Max production to 47 jets per month Business News
• Abercrombie shares jump 12% on earnings beat even as Iran conflict hits sales Business News